1. Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application
   Sanjit K. Roy et al, 2023, J Cellular Molecular Medi CrossRef
2. Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
   Fernanda Villarruel-Melquiades et al, 2023, World J Gastroenterol CrossRef
3. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer
   Qin Yang et al, 2023, Chin J Physiol CrossRef
4. PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway
   Long Fang et al, 2023, Sci Rep CrossRef
5. Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway
   Liu-jing Cao et al, 2024, Chin. J. Integr. Med. CrossRef
6. Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization
   Yilong Lin et al, 2024, Discov Onc CrossRef
7. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma
   Sanjit K. Roy et al, 2024, J Cellular Molecular Medi CrossRef
8. Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration
   Yinhui Qin et al, 2024, Heliyon CrossRef
9. Ribosome Biogenesis and Cancer: Insights into NOB1 and PNO1 Mechanisms
   Muthu Ragunath et al, 2024, CPD CrossRef
10. miR-326 overexpression inhibits colorectal cancer cell growth and proteasome activity by targeting PNO1: unveiling a novel therapeutic intervention strategy
    Yi Fang et al, 2024, Sci Rep CrossRef